ENDRA Life Sciences (NDRA) Net Cash Flow Growth (5y) (2021 - 2026)
ENDRA Life Sciences (NDRA) Net Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.96% |
| Mar 31, 2026 | -15.35% |
| Dec 31, 2025 | -14.98% |
| Sep 30, 2025 | -18.47% |
| Jun 30, 2025 | 35.82% |
| Mar 31, 2025 | 17.63% |
| Dec 31, 2024 | -19.02% |
| Sep 30, 2024 | -192.75% |
| Jun 30, 2024 | 38.93% |
| Mar 31, 2024 | 7.77% |
| Dec 31, 2023 | -15.84% |
| Sep 30, 2023 | 1.09% |
| Jun 30, 2023 | 35.75% |
| Mar 31, 2023 | -0.66% |
| Dec 31, 2022 | -17.85% |
| Sep 30, 2022 | -42.94% |
| Jun 30, 2022 | -10.90% |
| Mar 31, 2022 | -190.54% |
| Dec 31, 2021 | -33.68% |
| Sep 30, 2021 | -69.60% |